Generation Bio Co (NAS:GBIO)
$ 2.64 -0.13 (-4.69%) Market Cap: 176.20 Mil Enterprise Value: 53.21 Mil PE Ratio: 0 PB Ratio: 1.61 GF Score: 34/100

Generation Bio Co at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 05:30PM GMT
Release Date Price: $4.78 (+9.38%)
Operator

Hello, everyone. Welcome to the 2023 Jefferies Healthcare Conference. We have Geoff McDonough from Generation Bio.

Eun Yang
Jefferies - Analyst

Good afternoon, everyone. This is Eun Yang, a Biotech Analyst with Jefferies. Happy to have a fireside chat with Geoff from Generation Bio. So before we start the Q&As, Geoff is going to give us some overview of the company, and then we go into Q&A often.

Geoff McDonough
Generation Bio Co. - MD, President and CEO

Awesome. Thank you, Eun. Thank you, Jeff, for the intro. Very fun to be back together live, it's been a long time. I'll just show a few slides, give you a thumbnail of where the Generation Bio is coming from, what we're up to. This is genetic medicine company. We're in the business of making nonviral DNA therapeutics to reality for the world. Just as a reminder, before I go through the overview, these are forward-looking statements. A reminder that not everything we predict will happen, will happen.

So the company today is really in the position

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot